Post-approval studies (Phase 4)Ended earlyNCT00972543What this trial is testingRaptiva in Palm and Sole PsoriasisWho this might be right forChronic Plaque Psoriasis Merck KGaA, Darmstadt, Germany 6
Not applicableStudy completedNCT04433442What this trial is testingStudy to Assess the Safety and Change in Disease Symptoms of Risankizumab (Skyrizi) in Adult Participants With Moderate to Severe Plaque Psoriasis and Psoriatic ArthritisWho this might be right forPsoriasisPsoriatic Arthritis AbbVie 2,324
Testing effectiveness (Phase 2)Ended earlyNCT02201524What this trial is testingStudy to Evaluate PF-04965842 in Patients With Moderate to Severe PsoriasisWho this might be right forPlaque Psoriasis Pfizer 59
Not applicableLooking for participantsNCT04334031What this trial is testingDeployment o the Multidisciplinary Prospective Cohort ImminentWho this might be right forChronic Inflammatory DiseaseAngioedemaSevere Asthma+6 more University Hospital, Lille 2,200
Post-approval studies (Phase 4)Study completedNCT00932113What this trial is testingMechanism of Action Study for PsoriasisWho this might be right forPsoriasis Tufts Medical Center 33
Early research (Phase 1)UnknownNCT02918123What this trial is testingSafety of FURESTEM-CD Inj. in Patients With Moderate to Severe Plaque-type PsoriasisWho this might be right forPsoriasis Kang Stem Biotech Co., Ltd. 9
Large-scale testing (Phase 3)Active Not RecruitingNCT06846541What this trial is testingLong-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque PsoriasisWho this might be right forPlaque PsoriasisPsoriasis (PsO)Psoriasis+2 more Alumis Inc 1,680
Testing effectiveness (Phase 2)Study completedNCT04718896What this trial is testingAssess the Pharmacokinetics, Safety, and Efficacy of Two Doses of Bimekizumab in Adolescent Study Participants With Moderate to Severe Plaque PsoriasisWho this might be right forModerate to Severe Plaque Psoriasis UCB Biopharma SRL 41
Not applicableStudy completedNCT00678470What this trial is testingOpen Label Study of Alefacept Injections to Patients With Moderate to Severe PsoriasisWho this might be right forModerate to Severe Psoriasis University of California, San Francisco 18
Not applicableWithdrawnNCT01758705What this trial is testingPost Marketing Observational Study on Venezuelan Patients With PsoriasisWho this might be right forModerate to Severe Chronic Plaque Psoriasis AbbVie (prior sponsor, Abbott)
Large-scale testing (Phase 3)Study completedNCT02074982What this trial is testingEfficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type PsoriasisWho this might be right forChronic Plaque Type Psoriasis Novartis Pharmaceuticals 676
Post-approval studies (Phase 4)Study completedNCT04571567What this trial is testingEvaluate the Efficacy and Safety of Secukinumab in Adult Patients With Skin Types IV-VI With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Saakshi Khattri 20
Large-scale testing (Phase 3)Study completedNCT03390101What this trial is testingAn International Multicenter, Randomized, Double-blind, Placebo-Controlled Clinical Study of Efficacy and Safety of Two Dosing Regimens of BCD-085 (JSC BIOCAD, Russia) in Patients With Moderate to Severe Plaque PsoriasisWho this might be right forModerate to Severe Plaque Psoriasis Biocad 213
Large-scale testing (Phase 3)Not Yet RecruitingNCT07530367What this trial is testingA Phase III Randomized Controlled Trial Evaluating the Efficacy and Safety of Tofacitinib Combined With Imatinib in Patients With Moderate-to-Severe Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis (PPP) Second Affiliated Hospital, School of Medicine, Zhejiang University 135
Testing effectiveness (Phase 2)Study completedNCT02905006What this trial is testingStudy to Evaluate Safety and Efficacy of Different Doses of Bimekizumab in Patients With Chronic Plaque PsoriasisWho this might be right forChronic Plaque Psoriasis UCB Biopharma S.P.R.L. 250
Large-scale testing (Phase 3)Study completedNCT00679731What this trial is testingSafety and Efficacy Comparing ABT-874 Versus Methotrexate in Subjects With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis AbbVie (prior sponsor, Abbott) 317
Early research (Phase 1)Study completedNCT03058744What this trial is testingTopically Applied IDP-118 Lotion and HP Monad Lotion in Subjects With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Bausch Health Americas, Inc. 94
Large-scale testing (Phase 3)Study completedNCT00747344What this trial is testingTrial to Look at the Safety and Effectiveness of Ustekinumab in Korean and Taiwanese Subjects With Moderate to Severe Plaque-type PsoriasisWho this might be right forPsoriasis Centocor, Inc. 121
Testing effectiveness (Phase 2)Study completedNCT04172233What this trial is testingA Clinical Study of AK101 in Subjects With Moderate to Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Akeso 96
Large-scale testing (Phase 3)Study completedNCT02207244What this trial is testingGuselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and RetreatmentWho this might be right forPsoriasis Janssen Research & Development, LLC 992